LU70477A1 - - Google Patents
Info
- Publication number
- LU70477A1 LU70477A1 LU70477A LU70477A LU70477A1 LU 70477 A1 LU70477 A1 LU 70477A1 LU 70477 A LU70477 A LU 70477A LU 70477 A LU70477 A LU 70477A LU 70477 A1 LU70477 A1 LU 70477A1
- Authority
- LU
- Luxembourg
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3227373A GB1472534A (en) | 1973-07-06 | 1973-07-06 | 7beta-hydroxyiminoacylamido-cephalosporins |
Publications (1)
Publication Number | Publication Date |
---|---|
LU70477A1 true LU70477A1 (es) | 1976-05-31 |
Family
ID=10336049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU70477A LU70477A1 (es) | 1973-07-06 | 1974-07-05 |
Country Status (16)
Country | Link |
---|---|
US (1) | US4007174A (es) |
JP (1) | JPS5069093A (es) |
AT (1) | AT335061B (es) |
BE (1) | BE817304A (es) |
CA (1) | CA1055016A (es) |
CH (1) | CH615436A5 (es) |
DE (1) | DE2432415A1 (es) |
DK (1) | DK360874A (es) |
ES (1) | ES428015A1 (es) |
FR (1) | FR2235696B1 (es) |
GB (1) | GB1472534A (es) |
IE (1) | IE39595B1 (es) |
LU (1) | LU70477A1 (es) |
NL (1) | NL7409179A (es) |
SE (1) | SE7408892L (es) |
ZA (1) | ZA744349B (es) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4092477A (en) * | 1971-05-14 | 1978-05-30 | Glaxo Laboratories Limited | 7β-[2-Etherified oximino-2-(phenyl- or naphthylacetamido)] cephalosporins |
DE2760123C2 (de) * | 1976-01-23 | 1986-04-30 | Roussel-Uclaf, Paris | 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen |
US4165429A (en) * | 1976-06-28 | 1979-08-21 | Yamanouchi Pharmaceutical Co., Ltd. | 7α-METHOXY-CEPHALOSPORANIC ACID DERIVATIVES |
GB1592149A (en) * | 1976-10-08 | 1981-07-01 | Fujisawa Pharmaceutical Co | 3 7-disubstituted-3-cephem-4-carboxylic acid compounds and processes for preparation thereof |
SE439312B (sv) * | 1977-03-25 | 1985-06-10 | Roussel Uclaf | Sett att framstella nya oximderivat av 3-acetoximetyl-7-aminotiazolylacetamido cefalosporansyra |
US5574154A (en) * | 1994-09-29 | 1996-11-12 | Alnejma Bulk Pharmaceutical Co. A.B.P.C. | Process for the preparation of cephalosporanic compounds |
US6565882B2 (en) * | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
US6541014B2 (en) * | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
US20020068078A1 (en) * | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
US20020197314A1 (en) * | 2001-02-23 | 2002-12-26 | Rudnic Edward M. | Anti-fungal composition |
US8313776B2 (en) * | 2003-07-21 | 2012-11-20 | Shionogi Inc. | Antibiotic product, use and formulation thereof |
JP2006528190A (ja) * | 2003-07-21 | 2006-12-14 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質製剤、その使用法及び作成方法 |
JP2006528185A (ja) * | 2003-07-21 | 2006-12-14 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質製剤、その使用法及び作成方法 |
CA2535177A1 (en) * | 2003-08-11 | 2005-02-24 | Advancis Pharmaceutical Corporation | Robust pellet |
CA2535398C (en) * | 2003-08-12 | 2013-11-12 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
AU2004270170B2 (en) * | 2003-08-29 | 2011-01-27 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
WO2005027877A1 (en) * | 2003-09-15 | 2005-03-31 | Advancis Pharmaceutical Corporation | Antibiotic product, use and formulation thereof |
CA2550983C (en) * | 2003-12-24 | 2013-09-17 | Advancis Pharmaceutical Corporation | Enhanced absorption of modified release dosage forms |
JP2008505124A (ja) * | 2004-07-02 | 2008-02-21 | アドバンシス ファーマスーティカル コーポレイション | パルス送達用錠剤 |
US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
US8778924B2 (en) * | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
US8299052B2 (en) * | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE311519B (es) * | 1962-12-14 | 1969-06-16 | Astra Ab | |
GB1208015A (en) * | 1967-03-23 | 1970-10-07 | Glaxo Lab Ltd | Cephalosporins |
US3573294A (en) * | 1968-03-14 | 1971-03-30 | Glaxo Lab Ltd | 7 - (arylglyoxamido)cephalosporanic acids and their salts and alpha-carbonyl derivatives |
GB1389194A (en) * | 1971-01-29 | 1975-04-03 | Glaxo Lab Ltd | Antibiotics |
GB1433141A (en) * | 1972-07-07 | 1976-04-22 | Glaxo Lab Ltd | Antibiotics |
-
1973
- 1973-07-06 GB GB3227373A patent/GB1472534A/en not_active Expired
-
1974
- 1974-07-01 US US05/485,233 patent/US4007174A/en not_active Expired - Lifetime
- 1974-07-05 JP JP49077193A patent/JPS5069093A/ja active Pending
- 1974-07-05 ES ES428015A patent/ES428015A1/es not_active Expired
- 1974-07-05 LU LU70477A patent/LU70477A1/xx unknown
- 1974-07-05 DK DK360874A patent/DK360874A/da unknown
- 1974-07-05 DE DE2432415A patent/DE2432415A1/de not_active Withdrawn
- 1974-07-05 IE IE1436/74A patent/IE39595B1/xx unknown
- 1974-07-05 FR FR7423534A patent/FR2235696B1/fr not_active Expired
- 1974-07-05 NL NL7409179A patent/NL7409179A/xx not_active Application Discontinuation
- 1974-07-05 AT AT556074A patent/AT335061B/de not_active IP Right Cessation
- 1974-07-05 BE BE146263A patent/BE817304A/xx unknown
- 1974-07-05 SE SE7408892A patent/SE7408892L/xx unknown
- 1974-07-05 ZA ZA00744349A patent/ZA744349B/xx unknown
- 1974-07-05 CH CH927374A patent/CH615436A5/de not_active IP Right Cessation
- 1974-07-05 CA CA204,132A patent/CA1055016A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
ATA556074A (de) | 1976-06-15 |
ES428015A1 (es) | 1976-07-16 |
SE7408892L (es) | 1975-01-07 |
JPS5069093A (es) | 1975-06-09 |
IE39595B1 (en) | 1978-11-22 |
US4007174A (en) | 1977-02-08 |
CH615436A5 (en) | 1980-01-31 |
DK360874A (es) | 1975-03-03 |
FR2235696A1 (es) | 1975-01-31 |
NL7409179A (nl) | 1975-01-08 |
IE39595L (en) | 1975-01-06 |
AU7072374A (en) | 1976-01-08 |
BE817304A (fr) | 1975-01-06 |
DE2432415A1 (de) | 1975-01-30 |
CA1055016A (en) | 1979-05-22 |
AT335061B (de) | 1977-02-25 |
GB1472534A (en) | 1977-05-04 |
FR2235696B1 (es) | 1976-12-24 |
ZA744349B (en) | 1975-07-30 |